Genome Editing Market Size 2021-2028 - Rising Application Of Genome Editing In Biotechnology & Biomedical Research Is A Key Revenue Growth Driving Factor

Rising prevalence of genetic abnormalities and increasing drug discoveries are key factors driving global genome editing market revenue growth 

The global genome editing market size is expected to reach USD 19.06 billion in 2028 and register a CAGR of 17.2% over the forecast period, according to the latest report by Reports and Data. Some of the key factors driving genome editing market revenue growth include rapid advancements of gene editing technologies, rising prevalence of genetic abnormalities, and increasing investment by government & private investors in biotechnology & biomedical research activities. Genome editing, also known as gene editing or genome engineering is a method that is used to change, alter, or modify an organism’s gene sequence.

Genome editing is performed using different types of technologies such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Zinc-finger Nucleases (ZFNs), Transcription Activator-like Effector Nucleases (TALEN), antisense, and others. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) is a unique gene editing technology containing two significant components, namely, gRNA or guide RNA and an enzyme called Cas9. CRISPR segment accounted for largest revenue share in the global market in 2020. Increasing use of CRISPR in gene alteration process due to its different benefits such as cost-effectiveness, ease of use, and others would drive growth of this segment. Transcription Activator-like Effector Nucleases (TALEN), on the other hand, is a state-of-the-art technology consisting two operational domains, namely, DNA nuclease domain and TALE or DNA-recognition transcription activator-like effector.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1052

Some Key Highlights From the Report:

  • In September 2021, KromaTiD launched dGH Screen, its latest product for mapping the human genome in single cells. This tool utilizes the company’s Directional Genomic Hybridization (dGH) technology to measure genomic structure and structural variation. Researchers can visualize structures of the human genome and discover variations at a resolution of 5 kilobases.
  • Pharmaceutical companies segment accounted for majority revenue share in the global market in 2020. Increasing prevalence of infectious diseases is one of the crucial factors boosting revenue growth of this segment.
  • Asia Pacific is expected to register a relatively faster revenue CAGR throughout the forecast period. This can be attributed to growing emphasis on drug discovery and development activities in the region. 
  • Some companies in the market report include Thermo Fisher Scientific, Merck & Co, Horizon Discovery Limited, Lonza, GenScript, Eurofins Scientific, Precision Biosciences, Oxford Genetics, Intellia Therapeutics, and Sangamo Therapeutics.

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/1052

For the purpose of this report, Reports and Data has segmented global genome editing market based on technology, product & service, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2018-2028)

  • Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
  • Zinc-finger Nucleases (ZFNs)
  • Transcription Activator-like Effector Nucleases (TALEN)
  • Antisense
  • Others

Product and Service Outlook (Revenue, USD Billion; 2018-2028)

  • Software & Systems
  • Reagents & Consumables
  • Services

Application Outlook (Revenue, USD Billion; 2018-2028)

  • Cell Line Engineering
  • Diagnostic Applications
  • Genetic Engineering
  • Drug Discovery & Development
  • Others

End-Use Outlook (Revenue, USD Billion; 2018-2028)

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Government Research Institutes

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/1052

Regional Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • BENELUX
    • Rest of APAC
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • U.A.E.
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:   

Clinical Immunoanalyzer Market  Size, Share & Trends Analysis Report by Product (CLIA, ELISA, FIA, Others), by Application (Hospital, Clinic, Others), by Region, Competitive Strategies and Segment Forecasts, 2016-2026

Medical Alert Systems Market  By Type (Landline Type, Mobile Type, Standalone type), By Application Type (Inside The Home, Outside The Home), And Region-Global Forecast To 2027

Erythrocyte Sedimentation Rate (ESR) Analyzers Market  Size, Share & Analysis, By Type (Automatic Sedimentation Rate Analyzer, Semi-automatic Sedimentation Rate Analyzer, Manual Sedimentation Rate Analyzer), By End-user (Hospitals, Diagnostic Laboratories, Academic & Research Institutes, Others), And By Region, Forecast To 2027

Needle Free Injection Systems Market  By Type (Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors), By Application (Vaccine Delivery, Insulin Delivery, Others), And Region- Global Forecasts To 2027
 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-genome-editing-market
 

 

    

 

 

Back to news